logologo
QuantliQuantli

Teva Pharmaceutical Industries Ltd

TEVA

NYSE

Pharmaceuticals

$34.71

USD

+3.04 (+9.60%)

At close: Jul 29, 2026, 4:00 PM EDT

Market Cap $36.24B

Volume 17.8M

Price (USD)
Price (USD)

About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The company employs 31,173 full-time employees The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

CEO

Mr. Richard Francis

HQ

TEL AVIV-YAFO, IL

Founded

1951

Employees

31,173

Quantli Score

8.4

Outperform

Fin. Health

8.1

Profitability

7.6

Growth

9.0

Cash-Flow Q.

8.8

Key Metrics

6 metrics our research team weighs before forming a view on TEVA.

Based on Quantli research · SEC filings · as of Q1 2026

METRIC

VALUE

CHANGE

TREND (3Y)

Revenue Growth (TTM)

4.4%

+0.6 pp

Gross Margin (TTM)

52.1%

+2.9 pp

Operating Margin (TTM)

13.2%

+10.6 pp

Net Margin (TTM)

9.0%

+17.0 pp

ROE (TTM)

19.0%

+40.1 pp

Free Cash Flow (TTM)

$1.17B

+53.0%

Financial Snapshot

Full Financials

Revenue

$17.35B

+4.4%

YoY

Gross Margin

52%

TTM

+5.9%

YoY

Net Income

$1.57B

+218.8%

YoY

Operating Cash Flow

$1.71B

+35.3%

YoY

Key Statistics

Open

$33.67

Previous Close

$31.67

Day Range

$33.48 - $35.69

52 Week Range

$14.99 - $37.35

Volume

17.8M

Average Volume (10 Days)

860.0K

Market Cap

$36.24B

P/E Ratio (TTM)

23.25

P/S Ratio (TTM)

2.09

Dividend Yield

Valuation Measurement

Market Cap

$36.24B

Trailing P/E

23.25

Price / Sales

2.09

Price / Book

4.40

Financial Highlights

Profit Margin

9.0%

Return on Assets

3.9%

Return on Equity

19.0%

Revenue (TTM)

$17.35B

Net Income (TTM)

$1.57B

Diluted EPS (TTM)

$1.33

Total Cash (MRQ)

$3.74B

Levered FCF (TTM)

$1.17B

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Go deeper on TEVA

Analyst Consensus

Buy

Based on 1 analyst ratings

Avg Target: $40.00

(+15.2% upside)

High: $40.00 · Low: $40.00

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

View full analyst ratings